Literature DB >> 7398135

Angiotensin, hypoxia, verapamil and pulmonary vessels.

A J Suggett, F H Mohammed, G R Barer.   

Abstract

1. The action of angiotensin II on lung vessels was compared in dogs, cats, ferrets and rats using isolated perfused lungs and lobes of lungs perfused in vivo, both at constant flow, so that increases in inflow pressure at constant outflow pressure indicated increases in resistance. 2. Angiotensin II caused some increases in resistance in dogs, cats and rats but not ferrets. The increases were small compared with changes in the systemic circulation. Larger increases could be obtained in isolated lungs where there was no interference from rises in left atrial pressure. 3. All four species showed pulmonary vasoconstriction during hypoxia and ferret lungs were especially responsive. Thus angiotensin II cannot be the mediator of hypoxic vasoconstriction in all these species. 4. Angiotensin II significantly increased the response to hypoxia in isolated cat and rat lungs while also increasing baseline inflow pressure; the response to hypoxia was not altered in ferrets. Angiotensin II may therefore enhance reactivity of pulmonary vessels. 5. Verapamil, an inhibitor of calcium transport across cell membranes, reduced the response to hypoxia in rats and ferrets more than it reduced the response to angiotensin II in rats or prostaglandin F2 alpha in ferrets. Thus hypoxic pulmonary vasoconstriction probably involves transport of calcium.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7398135     DOI: 10.1111/j.1440-1681.1980.tb00070.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  5 in total

Review 1.  Pulmonary hypertension.

Authors:  J R Michael; W R Summer
Journal:  Lung       Date:  1985       Impact factor: 2.584

2.  Separate and combined use of verapamil, aspirin and captopril in experimental chronic pulmonary hypertension.

Authors:  D Kentera; D Susić; M Zdravković
Journal:  Basic Res Cardiol       Date:  1984 May-Jun       Impact factor: 17.165

3.  Effects of verapamil on pulmonary haemodynamics during hypoxaemia, at rest, and during exercise in patients with chronic obstructive pulmonary disease.

Authors:  S E Brown; G S Linden; R R King; G P Blair; D W Stansbury; R W Light
Journal:  Thorax       Date:  1983-11       Impact factor: 9.139

4.  Effects of SQ 14.225, an orally active inhibitor of angiotensin-converting enzyme, on hypoxic pulmonary hypertension and right ventricular hypertrophy in rats.

Authors:  D Kentera; D Susić; A Cvetković; G Djordjević
Journal:  Basic Res Cardiol       Date:  1981 May-Jun       Impact factor: 17.165

Review 5.  Hypoxic pulmonary vasoconstriction.

Authors:  J T Sylvester; Larissa A Shimoda; Philip I Aaronson; Jeremy P T Ward
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 46.500

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.